Clinomics Inc
KOSDAQ:352770
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinomics Inc
KOSDAQ:352770
|
KR |
Clinomics Inc
Clinomics, Inc. conducts bio and medical research activities. The company is headquartered in Ulsan, Ulsan. The company went IPO on 2020-12-04. The firm's main businesses are multi-omics-based service business and liquid biopsy-based cancer diagnosis and screening business. The multi-omics-based service business provides products and services that predict physical characteristics and diseases based on genome diagnosis and tests, and provides early diagnosis services for major diseases such as cancer based on multi-omics. The liquid biopsy-based cancer diagnosis and screening business sells medical devices that diagnose patients by extracting blood cells and deoxyribonucleic acid (DNA), and diagnostic and monitoring kits for cancer mutations in patients. The company is also develops products that diagnoses cancer early with blood.
Clinomics, Inc. conducts bio and medical research activities. The company is headquartered in Ulsan, Ulsan. The company went IPO on 2020-12-04. The firm's main businesses are multi-omics-based service business and liquid biopsy-based cancer diagnosis and screening business. The multi-omics-based service business provides products and services that predict physical characteristics and diseases based on genome diagnosis and tests, and provides early diagnosis services for major diseases such as cancer based on multi-omics. The liquid biopsy-based cancer diagnosis and screening business sells medical devices that diagnose patients by extracting blood cells and deoxyribonucleic acid (DNA), and diagnostic and monitoring kits for cancer mutations in patients. The company is also develops products that diagnoses cancer early with blood.
